Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 27-0250382 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Supporting, researching, and developing reproductive medicine in animals and to raise and expend funds for the support and advancement of Theriogenology.
Principal Officer
DR Marco Coutinho Da SIL
Total Revenue
$175K
FY2024
Total Expenses
$192K
FY2024
Net Assets
$404K
Program Ratio
65.3%
expenses on programs
Employees
0
Volunteers
0
Board Members
12
Voting
12
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.